Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Please find the attached Intimation.
Awaiting price reaction for this filing.
Cresanto Global Limited has informed the BSE that a Board of Directors meeting will be held on Tuesday, 12th August 2025 at the corporate office. The main agenda is to consider and approve the unaudited financial results for Q1 FY26 (quarter ended 30th June 2025), along with the Limited Review Report for the same period. The trading window for designated persons has been closed from 1st July 2025 and will reopen on 14th August 2025, i.e., 48 hours after the results are declared. The intimation was signed by Managing Director Prashant Nathmal Bajaj on 7th August 2025.
This is a routine regulatory filing ahead of the Q1 FY26 results announcement. Investors should watch for the actual financial numbers to be released on 12th August 2025, as they will indicate the company's quarterly performance.